Protein kinase C-ζ modulates thromboxane A2-mediated apoptosis in adult ventricular myocytes via Akt

被引:29
作者
Shizukuda, Y
Buttrick, PM
机构
[1] Univ Illinois, Dept Med, Cardiol Sect, Program Cardiovasc Sci, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2002年 / 282卷 / 01期
关键词
atypical protein kinase C; eicosanoids; Akt/protein kinase B; mitogen activated protein kinases;
D O I
10.1152/ajpheart.2002.282.1.H320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We hypothesized that thromboxane A(2) (TxA(2)) receptor stimulation directly induces apoptosis in adult cardiac myocytes. To investigate this, we exposed cultured adult rat ventricular myocytes (ARVM) to a TxA(2) mimetic [1S-[ 1alpha ,2alpha (Z),3beta (1E,3S*),4 alpha]]-7-[3-[3-hydroxy-4-(4-iodophenoxy)-1-butenyl]-7-oxabicyclo[ 2.2.1] hept-2-yl]-5-heptenoic acid (I-BOP) for 24 h. Stimulation with I-BOP induced apoptosis in a dose-dependent manner and was completely prevented by a TxA(2) receptor antagonist, SQ-29548. We further investigated the role of protein kinase C (PKC) in this process. TxA(2) stimulation resulted in membrane translocation of PKC-zeta but not PKC-alpha,-beta II, -delta, and -epsilon at 3 min and 1 h. The activation of PKC-zeta by I-BOP was confirmed using an immune complex kinase assay. Treatment of ARVM with a cell-permeable PKC-zeta pseudosubstrate peptide (zeta -PS) significantly attenuated apoptosis by I-BOP. In addition, I-BOP treatment decreased baseline Akt activity and its decrease was reversed by treatment with zeta -PS. The inhibition of phosphatidylinositol 3- kinase upstream of Akt by wortmannin or LY-294002 abolished the antiapoptotic effect of zeta -PS. Therefore, our results suggest that the activation of PKC-zeta modulates TxA(2) receptor-mediated apoptosis at least, in part, through Akt activity in adult cardiac myocytes.
引用
收藏
页码:H320 / H327
页数:8
相关论文
共 41 条
[1]   Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 [J].
Adderley, SR ;
Fitzgerald, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :5038-5046
[2]   The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells [J].
Aman, MJ ;
Lamkin, TD ;
Okada, H ;
Kurosaki, T ;
Ravichandran, KS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) :33922-33928
[3]  
Bardales RH, 1996, AM J PATHOL, V149, P821
[4]   PROTEIN KINASE-C-ZETA ISOFORM IS CRITICAL FOR MITOGENIC SIGNAL-TRANSDUCTION [J].
BERRA, E ;
DIAZMECO, MT ;
DOMINGUEZ, I ;
MUNICIO, MM ;
SANZ, L ;
LOZANO, J ;
CHAPKIN, RS ;
MOSCAT, J .
CELL, 1993, 74 (03) :555-563
[5]   Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53 [J].
Bialik, S ;
Geenen, DL ;
Sasson, IE ;
Cheng, R ;
Horner, JW ;
Evans, SM ;
Lord, EM ;
Koch, CJ ;
Kitsis, RN .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1363-1372
[6]   N-acylated serinol is a novel ceramide mimic inducing apoptosis in neuroblastoma cells [J].
Bieberich, E ;
Kawaguchi, T ;
Yu, RK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :177-181
[7]   The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3′-kinase [J].
Chesley, A ;
Lundberg, MS ;
Asai, T ;
Xiao, RP ;
Ohtani, S ;
Lakatta, EG ;
Crow, MT .
CIRCULATION RESEARCH, 2000, 87 (12) :1172-1179
[8]  
Chua CC, 1996, BBA-MOL CELL RES, V1313, P1
[9]   Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-beta [J].
Craven, PA ;
Studer, RK ;
DeRubertis, FR .
HYPERTENSION, 1996, 28 (02) :169-176
[10]   Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo - An apoptosis-independent model of dilated heart failure [J].
De Windt, LJ ;
Lim, HW ;
Taigen, T ;
Wencker, D ;
Condorelli, G ;
Dorn, GW ;
Kitsis, RN ;
Molkentin, JD .
CIRCULATION RESEARCH, 2000, 86 (03) :255-263